Biotechnology Industry Strengths and Facts FierceBiotech, an internationally recognized e-mail newsletter for the biotechnology industry, named New Jersey in January 2006 as one of the world’s top five growth markets for biotechnology. A report issued in April 2006 by the Biotechnology Industry Organization (BIO) and Battelle, found that New Jersey was the only state with specialization in all four measured bioscience sub sectors − drugs and pharmaceuticals, research testing and medical laboratories, medical devices and equipment, and agricultural feedstock and chemicals. 60% of all biotechnology products are developed on the East Coast of the United States, with 25% of that total in New Jersey. Highlights from the study conducted by Deloitte in the spring of 2007 include: The number of biotechnology-related jobs increased to 10,071 in 2006 from 7,834 in 2003, an increase of 28 % The average base salary in 2006, as reported by respondents to a survey, was approximately $86,800. The biotechnology industry indirectly supported 9,389 jobs and $644 million in income at vendor companies. Workers directly and indirectly supporting the biotechnology industry helped generate an additional 7,637 jobs and $351 million in compensation. Pharmaceutical Industry Strengths and Facts New Jersey's pharmaceutical and medical technology industry produced an economic impact of $26.5 billion for New Jersey's economy in 2006 as reported in the HealthCare Institute of New Jersey’s (HINJ) 2006 Report. The industry created 148,768 jobs with an average base salary of $97,501 and payroll impacts of $7.6 billion. (HINJ 2006 Report) Research and development investments of $7.5 billion and capital construction spending of $1.9 billion. (HINJ 2006 Report) 14 of the 25 largest pharmaceutical companies have a sizable presence in New Jersey. More than 73,045 patents were issued from 1984 to 2004. From 2000 to 2004, drug, bio affecting and body treating compositions patents totaled almost 2,000.